Mutant IDH1 inhibits PI3K/Akt signaling in human glioma
BACKGROUND Recently, isocitrate dehydrogenase 1 (IDH1) was identified as a major participant in glioma pathogenesis. At present, the enzymatic activity of the protein has been the main topic in investigating its physiological function, but its signaling pathway allocation was unsuccessful. Interesti...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
April 25, 2014
|
| In: |
Cancer
Year: 2014, Jahrgang: 120, Heft: 16, Pages: 2440-2447 |
| ISSN: | 1097-0142 |
| DOI: | 10.1002/cncr.28732 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/cncr.28732 Verlag, lizenzpflichtig, Volltext: https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.28732 
|
| Verfasserangaben: | Peter Birner, MD, Stefan Pusch, PhD, Christo Christov, MD, Stiliana Mihaylova, MD, Kalina Toumangelova‐Uzeir, MS, Sevdalin Natchev, MD, Sebastian F. Schoppmann, MD, Andrey Tchorbanov, PhD, Berthold Streubel, Md, Jochen Tuettenberg, MD, and Marin Guentchev, MD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1730480128 | ||
| 003 | DE-627 | ||
| 005 | 20220818194621.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200911s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cncr.28732 |2 doi | |
| 035 | |a (DE-627)1730480128 | ||
| 035 | |a (DE-599)KXP1730480128 | ||
| 035 | |a (OCoLC)1341359459 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Birner, Peter |e VerfasserIn |0 (DE-588)1216128138 |0 (DE-627)1727330730 |4 aut | |
| 245 | 1 | 0 | |a Mutant IDH1 inhibits PI3K/Akt signaling in human glioma |c Peter Birner, MD, Stefan Pusch, PhD, Christo Christov, MD, Stiliana Mihaylova, MD, Kalina Toumangelova‐Uzeir, MS, Sevdalin Natchev, MD, Sebastian F. Schoppmann, MD, Andrey Tchorbanov, PhD, Berthold Streubel, Md, Jochen Tuettenberg, MD, and Marin Guentchev, MD |
| 264 | 1 | |c April 25, 2014 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.09.2020 | ||
| 520 | |a BACKGROUND Recently, isocitrate dehydrogenase 1 (IDH1) was identified as a major participant in glioma pathogenesis. At present, the enzymatic activity of the protein has been the main topic in investigating its physiological function, but its signaling pathway allocation was unsuccessful. Interestingly, proteins regulated by phosphoinositide 3-kinase (PI3K)/Akt signaling, are among the top downregulated genes in gliomas associated with high percentage of IDH1 and IDH2 mutations. The aim of this study was to investigate a hypothetical relation between IDH1 and PI3K signaling. METHODS The presence of mutant IDH1 and markers for active PI3K/Akt signaling, present as phosphorylated Akt and podoplanin (PDPN), were investigated in a discovery cohort of 354 patients with glioma. In vitro experiments were used to confirm functional links. RESULTS This study shows an inverse correlation between mutant IDH1 and markers for active PI3K/Akt signaling. In support of a functional link between these molecules, in vitro expression of mutant IDH1 inhibited Akt phosphorylation in a 2-hydroxyglutarate-dependent manner. CONCLUSIONS This study provides patient tumor and in vitro evidence suggesting that mutant IDH1 inhibits PI3K/Akt signaling. Cancer 2014;120:2440-2447. © 2014 American Cancer Society. | ||
| 650 | 4 | |a Akt | |
| 650 | 4 | |a astrocytoma | |
| 650 | 4 | |a glioblastoma | |
| 650 | 4 | |a glioma | |
| 650 | 4 | |a IDH1 | |
| 650 | 4 | |a PDPN | |
| 700 | 1 | |a Pusch, Stefan |d 1979- |e VerfasserIn |0 (DE-588)137014155 |0 (DE-627)58945224X |0 (DE-576)30150623X |4 aut | |
| 700 | 1 | |a Christov, Christo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mihaylova, Stiliana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Toumangelova‐Uzeir, Kalina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Natchev, Sevdalin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schoppmann, Sebastian F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tchorbanov, Andrey |e VerfasserIn |4 aut | |
| 700 | 1 | |a Streubel, Berthold |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tüttenberg, Jochen |d 1970- |e VerfasserIn |0 (DE-588)12164362X |0 (DE-627)081440790 |0 (DE-576)292812744 |4 aut | |
| 700 | 1 | |a Guentchev, Marin |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer |d New York, NY : Wiley-Liss, 1948 |g 120(2014), 16, Seite 2440-2447 |h Online-Ressource |w (DE-627)271350334 |w (DE-600)1479932-7 |w (DE-576)078590884 |x 1097-0142 |7 nnas |a Mutant IDH1 inhibits PI3K/Akt signaling in human glioma |
| 773 | 1 | 8 | |g volume:120 |g year:2014 |g number:16 |g pages:2440-2447 |g extent:8 |a Mutant IDH1 inhibits PI3K/Akt signaling in human glioma |
| 856 | 4 | 0 | |u https://doi.org/10.1002/cncr.28732 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.28732 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200911 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 137014155 |a Pusch, Stefan |m 137014155:Pusch, Stefan |p 2 | ||
| 999 | |a KXP-PPN1730480128 |e 3749909024 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"8 S."}],"title":[{"title":"Mutant IDH1 inhibits PI3K/Akt signaling in human glioma","title_sort":"Mutant IDH1 inhibits PI3K/Akt signaling in human glioma"}],"relHost":[{"id":{"doi":["10.1002/(ISSN)1097-0142"],"zdb":["1479932-7"],"eki":["271350334"],"issn":["1097-0142"]},"recId":"271350334","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Mutant IDH1 inhibits PI3K/Akt signaling in human gliomaCancer","origin":[{"dateIssuedKey":"1948","publisherPlace":"New York, NY","dateIssuedDisp":"1948-","publisher":"Wiley-Liss"}],"note":["Gesehen am 06.12.2011"],"pubHistory":["1.1948 -"],"titleAlt":[{"title":"Cancer cytopathology"}],"language":["eng"],"part":{"volume":"120","text":"120(2014), 16, Seite 2440-2447","issue":"16","pages":"2440-2447","year":"2014","extent":"8"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Cancer","subtitle":"interdisciplinary international journal of the American Cancer Society","title_sort":"Cancer"}]}],"person":[{"display":"Birner, Peter","family":"Birner","role":"aut","given":"Peter"},{"given":"Stefan","display":"Pusch, Stefan","family":"Pusch","role":"aut"},{"display":"Christov, Christo","family":"Christov","role":"aut","given":"Christo"},{"display":"Mihaylova, Stiliana","role":"aut","family":"Mihaylova","given":"Stiliana"},{"role":"aut","family":"Toumangelova‐Uzeir","display":"Toumangelova‐Uzeir, Kalina","given":"Kalina"},{"given":"Sevdalin","display":"Natchev, Sevdalin","family":"Natchev","role":"aut"},{"given":"Sebastian F.","display":"Schoppmann, Sebastian F.","role":"aut","family":"Schoppmann"},{"role":"aut","family":"Tchorbanov","display":"Tchorbanov, Andrey","given":"Andrey"},{"family":"Streubel","role":"aut","display":"Streubel, Berthold","given":"Berthold"},{"role":"aut","family":"Tüttenberg","display":"Tüttenberg, Jochen","given":"Jochen"},{"family":"Guentchev","role":"aut","display":"Guentchev, Marin","given":"Marin"}],"note":["Gesehen am 11.09.2020"],"language":["eng"],"origin":[{"dateIssuedDisp":"April 25, 2014","dateIssuedKey":"2014"}],"name":{"displayForm":["Peter Birner, MD, Stefan Pusch, PhD, Christo Christov, MD, Stiliana Mihaylova, MD, Kalina Toumangelova‐Uzeir, MS, Sevdalin Natchev, MD, Sebastian F. Schoppmann, MD, Andrey Tchorbanov, PhD, Berthold Streubel, Md, Jochen Tuettenberg, MD, and Marin Guentchev, MD"]},"id":{"eki":["1730480128"],"doi":["10.1002/cncr.28732"]},"recId":"1730480128","type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a BIRNERPETEMUTANTIDH12520 | ||